Citations

Clear

3030 citation(s) found for "Susan, M".

Lipid droplet breakdown requires Dynamin 2 for vesiculation of autolysosomal tubules in hepatocytes
Schulze, Ryan J. , Weller, Shaun G. , Schroeder, Barbara, Krueger, Eugene W. , Chi, Susan , McNiven, Mark A. , Casey, Carol A.

Mayo Clinic

Journal of Cell Biology | October 21, 2013 | Volume: 203 | Issue: 2 | Pages: 315-326

10.1083/jcb.201306140 | PMID 24145164 Get It

Lipid droplets (LDs) are lipid storage organelles that in hepatocytes may be catabolized by autophagy for use as an energy source, but the membrane-trafficking machinery regulating such a process is poorly characterized. We hypothesized that the large GTPase Dynamin 2 (Dyn2), well known for its involvement in membrane deformation and cellular protein trafficking, could orchestrate autophagy-mediated LD breakdown. Accordingly, depletion or pharmacologic inhibition of Dyn2 led to a substantial accumulation of LDs in hepatocytes. Strikingly, the targeted disruption of Dyn2 induced a dramatic four- to fivefold increase in the size of autolysosomes. Chronic or acute Dyn2 inhibition combined with nutrient deprivation stimulated the excessive tubulation of these autolysosomal compartments. Importantly, Dyn2 associated with these tubules along their length, and the tubules vesiculated and fragmented in the presence of functional Dyn2. These findings provide new evidence for the participation of the autolysosome in LD metabolism and demonstrate a novel role for dynamin in the function and maturation of an autophagic compartment.
Increased parental history of bipolar disorder in the United States: association with early age of onset
Post, Robert M. , Leverich, Gabriele S., Kupka, Ralph , Keck, P E, Altshuler, Lori L., Frye, Mark A. , Luckenbaugh, David A., Grunze, Heinz , Suppes, Trisha, Nolen, Willem A. , McElroy, Susan L. , Rowe, Michael J. , Grunze, Heinz

Mayo Clinic

Acta Psychiatrica Scandinavica | October 19, 2013 | Volume: 129 | Issue: 5 | Pages: 375-382

10.1111/acps.12208 | PMID 24138298 Get It

ObjectiveEarly‐onset bipolar (BP) disorder and other poor prognosis characteristics are more prevalent in patients from the United States than from the Netherlands and Germany (abbreviated as Europe). We explored the impact of parental loading for affective illness on onset and other characteristics of BP disorder.MethodParental history for unipolar (UP) and bipolar (BP) depression and course of illness characteristics were obtained from self‐report in adults (average age 42) with BP disorder. Illness characteristics were examined by χ2 and multinomial logistic regression in relationship to the degree of parental loading: i) both parents negative; ii) one UP disorder; iii) one with BP disorder; and iv) both affected.ResultsAfter controlling for many poor prognosis factors, compared with those from Europe, patients from the United States had more iii) one parent with BP disorder and iv) both parents affected. An early age of onset of BP disorder was independently associated with this increased parental loading for affective disorder.ConclusionParental history of BP disorder and both parents with a mood disorder were more common in the United States than Europe and were associated with an early onset of bipolar disorder and other poor prognosis characteristics. These findings deserve replication and exploration of the potential mechanisms involved and their therapeutic implications.
Prognostic Significance of Pretreatment Serum Cytokines in Classical Hodgkin Lymphoma
Marri, Preethi, Hodge, Lucy S. , Maurer, Matthew J. , Ziesmer, Steven C., Link, Brian K. , Cerhan, James R. , Novak, Anne J. , Ansell, Stephen M. , Marri, Preethi Reddy, Slager, Susan L. , Habermann, Thomas M. , Maurer, Matthew , Cerhan, James R , Link, Brian K

Mayo Clinic

Clinical Cancer Research | October 19, 2013 | Volume: 19 | Issue: 24 | Pages: 6812-6819

10.1158/1078-0432.ccr-13-1879 | PMID 24141626 Get It

Abstract Purpose: Although the International Prognostic Score (IPS) is the gold standard for risk-stratifying patients with classical Hodgkin lymphoma (cHL), these criteria do not accurately predict outcome. As cytokines are critically involved in driving cHL, we tested whether pretreatment serum cytokine levels could provide additional prognostic information. Experimental Design: Thirty cytokines were measured in pretreatment serum from 140 patients with cHL and compared with 50 nonlymphoma controls. Patients were followed for event-free survival (EFS) and overall survival (OS), and Cox proportional hazards regression models were used to assess the association of individual cytokines and the cytokine profiles with outcome via unadjusted and IPS-adjusted HR. Results: Twelve cytokines (EGF, bFGF, G-CSF, HGF, IL-6, IL-8, IL-12, IL-2R, IP-10, MIG, TNF-α, and VEGF) were significantly (P < 0.05) higher in patients with cHL than controls; elevated levels of HGF, IL-6, IL-2R, IP-10, and MIG were all associated with poorer EFS. Only interleukin-2 receptor (IL-2R; P = 0.002) and interleukin (IL)-6 (P < 0.001) were independently prognostic. Patients with increased IL-6 and IL-2R had a significantly higher risk of early relapse and death, a finding that remained significant even after IPS-based risk stratification. Although elevated IL-6 and IL-2R correlated with the IPS, soluble CD30 (sCD30), and thymus and activation-related chemokine (TARC) levels, the two-cytokine model remained independently predictive of prognosis. Conclusions: Elevated pretreatment serum cytokines are associated with increased disease relapse and inferior survival in cHL. Thus, the pretreatment cytokine profile, particularly serum levels of IL-6 and IL-2R, may be used to identify patients with cHL at high risk for early-disease relapse. Clin Cancer Res; 19(24); 6812–9. ©2013 AACR.
Skin cancer prevention in annual performance of total skin examination, photoprotection counseling, and patient instruction of self‐skin examination
Yiannias, James A. , Laman, Susan D., Rkein, Ali M., Nelson, Evan Lloyd, Noble, Brie N. , Stevens, Ryan W.

Mayo Clinic

International Journal of Dermatology | October 18, 2013 | Volume: 53 | Issue: 8 | Pages: 981-984

10.1111/ijd.12066 | PMID 24134438 Get It

AbstractBackgroundPrevention of skin cancer includes early diagnosis and photoprotection, such as by physician‐performed total skin examination (TSE) and patient‐performed self‐skin examination (SSE). Hypothesizing that 90% of our patients receive an annual TSE, photoprotection counseling, and SSE instruction, we assessed the extent to which this was documented in patients' records. We also sought to identify differences in documentation of TSE, photoprotection counseling, and instruction on SSE with or without use of a dictation template prompting documentation.Materials and methodsRetrospective review of a random sample of 400 patients in an outpatient dermatology practice of a tertiary care academic medical center for any dermatology appointment between May 1 and July 31, 2007. Exclusion criteria included refusal to undergo TSE, lack of access to skin (e.g. wheelchair‐bound or in cast), or inappropriate visit type (e.g. for acne, psoriasis, or lupus).ResultsOf 400 randomly selected patients, 313 met inclusion criteria. The dictation template was used in 133; of these, 89% (119/133) had documentation in their clinical note of a TSE (exclusive of the buttocks or groin area), and 98% (130/133) had documentation of instruction on sun protection and SSE. Without use of the dictation template, these percentages dropped to 78% (140/180) and 20% (36/180), respectively. Physicians using a dictation template were more likely to document having conducted a TSE and instructed patients on photoprotection and SSE.ConclusionsA dictation template aids documentation of annual TSE and patient education efforts on photoprotection and SSE.
P3–205: Similar maximal educational attainment in people with dementia: Association with pathologically diagnosed frontotemporal lobar degeneration, Alzheimer's disease and Lewy body disease?
Bruns, Marla B., Bristow, Katherine, Monsell, Sarah E. , Aakre, Jeremiah A. , Graff‐Radford, Neill R. , Laden, Francine , Dickinson, Susan, Boeve, Bradley, Kukull, Walter A. , Pankratz, V. Shane , Knopman, David S. , Miller, Bruce L. , Mesulam, Marsel M.

Mayo Clinic

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_16 | Pages: No page available

10.1016/j.jalz.2013.05.1278 Get It

A Phase I Trial of Imetelstat in Children with Refractory or Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Study (ADVL1112)
Thompson, Patrick A., Drissi, Rachid , Muscal, Jodi A. , Panditharatna, Eshini , Fouladi, Maryam , Ingle, Ashish M., Ahern, Charlotte H., Lin, Tong , Weigel, Brenda J. , Blaney, Susan M. , Reid, Joel M.

Mayo Clinic

Clinical Cancer Research | October 5, 2013 | Volume: 19 | Issue: 23 | Pages: 6578-6584

10.1158/1078-0432.ccr-13-1117 | PMID 24097866 Get It

Abstract Purpose: Imetelstat is a covalently-lipidated 13-mer thiophosphoramidate oligonucleotide that acts as a potent specific inhibitor of telomerase. It binds with high affinity to the template region of the RNA component of human telomerase (hTERC) and is a competitive inhibitor of telomerase enzymatic activity. The purpose of this study was to determine the recommended phase II dose of imetelstat in children with recurrent or refractory solid tumors. Experimental Design: Imetelstat was administered intravenously more than two hours on days 1 and 8, every 21 days. Dose levels of 225, 285, and 360 mg/m2 were evaluated, using the rolling-six design. Imetelstat pharmacokinetic and correlative biology studies were also performed during the first cycle. Results: Twenty subjects were enrolled (median age, 14 years; range, 3–21). Seventeen were evaluable for toxicity. The most common toxicities were neutropenia, thrombocytopenia, and lymphopenia, with dose-limiting myelosuppression in 2 of 6 patients at 360 mg/m2. Pharmacokinetics is dose dependent with a lower clearance at the highest dose level. Telomerase inhibition was observed in peripheral blood mononuclear cells at 285 and 360 mg/m2. Two confirmed partial responses, osteosarcoma (n = 1) and Ewing sarcoma (n = 1), were observed. Conclusions: The recommended phase II dose of imetelstat given on days 1 and 8 of a 21-day cycle is 285 mg/m2. Clin Cancer Res; 19(23); 6578–84. ©2013 AACR.
Hand Instrument Performance in A Single Site Surgery Simulator With Novices
Riggle, Jakeb D. , Miller, Emily E., Meitl, Alex, Hallbeck, M. Susan , McCrory, Bernadette , Lim, Eric T.K. , LaGrange, Chad A. , Hallbeck, M Susan

Mayo Clinic

Proceedings of the Human Factors and Ergonomics Society Annual Meeting | September 30, 2013 | Volume: 57 | Issue: 1 | Pages: 1522-1526

10.1177/1541931213571339 Get It

Laparoendoscopic single-site surgery (LESS) is a new minimally invasive surgical technique that presents physical and mental challenges to surgeons. Currently, LESS procedures are commonly performed using surgical instruments designed for traditional multi-incision laparoscopic surgery. A pilot study was conducted to determine which laparoscopic instruments were the most efficient for LESS procedures. In a LESS surgical trainer, 24 novice users completed a simple surgical task using standard (non-articulating) straight laparoscopic graspers and two different articulating instruments. Task performance was scored based on completion time and the number of errors. Analyses showed that the use of the simpler straight instruments produced significantly faster times (p = 0.004 and p = 0.014) and higher task scores (p = 0.005 and p = 0.021) than the articulating instruments. These results suggest that standard laparoscopic hand instruments enable better novice performance for a basic LESS task.
Human Factors in the Wild
Abts, Natalie, Wolf, Laurie , Hallbeck, M. Susan , Taneva, Svetlena, Chagpar, Anjum, Probst, C. Adam, Xiao, Yan , Hallbeck, M Susan

Mayo Clinic

Proceedings of the Human Factors and Ergonomics Society Annual Meeting | September 30, 2013 | Volume: 57 | Issue: 1 | Pages: 1057-1060

10.1177/1541931213571235 Get It

This session will focus on lessons learned when developing solutions for real world problems in healthcare. Human factors (HF) practitioners bring unique knowledge, methods, and perspectives to work with clinicians to address numerous defects in the worksystem but require problem-solving skills that focus on solutions. The HF contribution may be in the area of process improvement (e.g., prevention of patient falls), systems design (e.g., designing crashcart), or identification of design flaws so robust intervention may be deployed (e.g., glucose meters). Six human factors practitioners who work within healthcare systems will present real world challenges which were discovered by HF methods, or which have heavy HF implications, but where direct HF influence on design lead to the ultimate effective solution. The session will be designed to lead to a discussion about how HF methods were adapted to individual problems at hand and to focus on developing solutions.
Laparoscopic Surgical Team Stress Measures During Randomized Controlled Trials of 4-port vs. Single Incision Cholecystecomies
Hallbeck, M. Susan , Lowndes, Bethany R. , Bingener, Juliane , Hallbeck, M Susan

Mayo Clinic

Proceedings of the Human Factors and Ergonomics Society Annual Meeting | September 30, 2013 | Volume: 57 | Issue: 1 | Pages: 654-657

10.1177/1541931213571141 Get It

The Institute of Medicine lists investigations of the comparative effectiveness for minimally invasive surgical procedures as a research priority. As new minimally invasive procedures are developed, comparisons of the resulting workload contribute valuable information about the impact of the new procedures. Recent reports suggest that surgeon workload can influence patient outcomes. Measurements of stress and fatigue for the surgical team participating in a randomized NIH supported trial of single incision versus traditional laparoscopic cholecystectomy were obtained. These stress measures showed that the SURG-TLX was sensitive to the difficulty of the surgery. The SURG-TLX and a surgical difficulty score was obtained from the surgical team for 16 laparoscopic surgeries by surgical approach (8 SILC and 8 4-port) showed that for this small sample size, there were no statistically significant differences in length of surgery, degree of difficulty, nor patient considerations such as post-operative pain scores. In addition, no statistically significant differences in the individual Surg-TLX subscale scores or Surg-TLX total for the surgical team overall or for the surgeon alone by surgical platform. This is likely due to the small sample size reducing the power of the tests.